Article 15 - Menstrual Products

California Health and Safety Code — §§ 25258-25258.7

Sections (8)

Added by Stats. 2024, Ch. 1008, Sec. 2. (AB 2515) Effective January 1, 2025.

For the purposes of this article, the following definitions apply:

(a)“Department” means the Department of Toxic Substances Control.
(b)“Menstrual product” means a product used to collect menstruation and vaginal discharge, including, but not limited to, tampons, pads, sponges, menstruation underwear, disks, and menstrual cups, whether disposable or reusable.
(c)“Perfluoroalkyl and polyfluoroalkyl substances” or “PFAS” means a class of fluorinated organic chemicals containing at least one fully fluorinated carbon atom.
(d)“Regulated perfluoroalkyl and polyfluoroalkyl

substances” or “regulated PFAS” means the following:

(1)Commencing January 1, 2025, PFAS that a manufacturer has intentionally added to a product and that have a functional or technical effect in the product, including the PFAS components of intentionally added chemicals and PFAS that are intentional breakdown products of an added chemical that also have a functional or technical effect in the product.
(2)Commencing January 1, 2027, the presence of PFAS in a product or product component at or above a limit determined by the department, as measured in total organic fluorine.

Added by Stats. 2024, Ch. 1008, Sec. 2. (AB 2515) Effective January 1, 2025.

On or before January 1, 2029, the department shall adopt regulations to implement, interpret, enforce, or make specific this article.

Added by Stats. 2024, Ch. 1008, Sec. 2. (AB 2515) Effective January 1, 2025.

On or before January 1, 2027, the department shall publish on its internet website a list of accepted testing methods for testing for the presence of regulated PFAS in menstrual products and appropriate third-party accreditations for laboratories. The department may update the list of accepted testing methods as necessary.

Added by Stats. 2024, Ch. 1008, Sec. 2. (AB 2515) Effective January 1, 2025.

A person shall not manufacture, distribute, sell, or offer for sale in the state a menstrual product that contains regulated PFAS.

Added by Stats. 2024, Ch. 1008, Sec. 2. (AB 2515) Effective January 1, 2025.

(a)On or before July 1, 2029, a manufacturer of a menstrual product, as defined in this article, shall register with the department and provide to the department all of the following in the manner prescribed by the department pursuant to the regulations adopted pursuant to this article:
(1)The name and a description of each menstrual product.
(2)The applicable registration fee.
(3)(A) A statement of compliance certifying that each menstrual product is in compliance with this article.
(B)The department may request, and a

manufacturer shall provide upon request, technical documentation, including analytical test results, to demonstrate compliance with this article. The certification and analytical tests shall comply with those published on the department’s internet website pursuant to Section 25258.2.

(b)The department shall specify in regulation the manner for registering and the registration fee. The registration fee shall not exceed the department’s reasonable costs of implementing this article.

Added by Stats. 2024, Ch. 1008, Sec. 2. (AB 2515) Effective January 1, 2025.

(a)The department shall issue a notice of violation to a person or entity in violation of this article if any of the following occurs:
(1)The department’s testing or test results submitted as a part of the registration process pursuant to Section 25258.4 indicates that a menstrual product contains regulated PFAS.
(2)The department determines that a menstrual product contains regulated PFAS after finding PFAS as an ingredient identified on the product’s label.
(3)The department finds a violation of this article or any rule, regulation, standard, or requirement issued or adopted pursuant to this article.
(b)A notice of violation shall indicate the nature of the violation and may do any of the following:
(1)Assess an administrative or civil penalty against a person or entity in violation of this article.
(2)Require compliance with this article, including requiring the person or entity to cease the manufacture, sale, or distribution of a menstrual product in this state.
(c)The department may receive reports of alleged violations, including analytical test results, from consumers, businesses, research institutions, persons, entities, and not-for-profit entities, and shall verify those alleged reports through its own independent testing, verification, or inspection.

Added by Stats. 2024, Ch. 1008, Sec. 2. (AB 2515) Effective January 1, 2025.

(a)A violation of this article is punishable by a civil and administrative penalty.
(b)The department shall determine, on a case-by-case basis, the enforcement mechanism and the amount of any administrative or civil penalty assessed pursuant to this article. The minimum amount of an administrative or civil penalty assessed shall be ten thousand dollars ($10,000) for the first and any subsequent violation. Penalties may be assessed for each violation of a separate provision or, for continuing violations, for each day that the violation continues.
(c)In assessing the amount of a civil penalty for a violation of this article, the court may consider all of the following:
(1)The nature and extent of the violation.
(2)The number and severity of the violations.
(3)The economic effect of the penalty on the violator.
(4)Whether the violator took good faith measures to comply with this article and when the measures were taken.
(5)The deterrent effect that the imposition of the penalty would have on both the violator and the regulated community as a whole.
(6)Whether there were contributing environmental factors about which a reasonable person knew or should have known.
(d)The Attorney General, on behalf of the department, may

bring an action in superior court and the court shall have jurisdiction upon hearing and for cause shown, to grant a temporary or permanent injunction restraining any person or entity from violating any provision of this article. A proceeding under this section shall conform to the requirements of Chapter 3 (commencing with Section 525) of Title 7 of Part 2 of the Code of Civil Procedure, except that the department shall not be required to allege facts necessary to show or tending to show lack of adequate remedy at law or to show or tending to show irreparable damage or loss.

(e)Actions may be brought pursuant to this section by the Attorney General in the name of the people of the state at the request of the department.
(f)A prevailing plaintiff bringing an action pursuant to this article shall be awarded attorney’s fees and costs by the court.
(g)(1) Moneys from penalties collected pursuant to this section shall be deposited in the T.A.M.P.O.N. Act Fund, which is hereby created in the State Treasury.
(2)The department’s duties to initiate, implement, or enforce any requirement of this article are contingent upon sufficient funds in the Toxic Substances Control Account, as determined by the Department of Finance, and an appropriation by the Legislature for the purposes of implementing and enforcing the requirements of this article.
(3)Upon appropriation by the Legislature and subject to the determination in paragraph (2), if funds in the Toxic Substances Control Account are sufficient to finance the development of the regulations and the startup costs of the department’s activities pursuant to this article, funds may be used as a loan

by the department for the department to carry out this article until the T.A.M.P.O.N. Act Fund generates revenues sufficient to fund the department’s reasonable costs of implementing this article and to reimburse any outstanding loans made from the Toxic Substances Control Account used to finance the development of the regulations and the startup costs of the department’s activities pursuant to this article.

Added by Stats. 2025, Ch. 604, Sec. 1. (SB 754) Effective January 1, 2026.

(a)On and after December 31, 2026, a manufacturer of disposable tampons or pad products shall maintain information regarding the concentrations of all of the following concerning chemicals in their disposable tampon or pad products:
(1)Lead (CAS no. 7439-92-1).
(2)Arsenic (CAS no. 7440-38-2).
(3)Cadmium (CAS no. 7440-43-9).
(4)Zinc (CAS no. 7440-66-6).
(b)(1) The

department may determine additional concerning chemicals from its list of candidate chemicals in disposable tampons or pad products and publish on its internet website a list of those chemicals. The department may make its determination pursuant to a finding that both of the following criteria have been met:

(A) The concerning chemical has been present or detected in disposable tampon or pad products.

(B) The concerning chemical has been found to have adverse public health impacts.

(2)The determination described in paragraph (1) shall be exempt from the Administrative Procedure Act (Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government

Code).

(c)The department may require a manufacturer of disposable tampons or pad products to maintain information regarding the concentrations of additional concerning chemicals determined pursuant to subdivision (b).
(d)(1) The department may publish on its internet website a list of acceptable testing methods, frequencies for testing, and appropriate third-party laboratory accreditations, for the testing of disposable tampon or pad products for the presence of concerning chemicals.
(2)The department may update the list of accepted testing methods as it deems necessary.
(e)(1) Upon request from the department, a manufacturer shall provide any technical documentation, including test methods and analytical test results, to assess the concentrations of chemicals referred to in subdivisions (a) and (c) in its disposable tampon or pad products. The department may also conduct its own tests to confirm the manufacturer’s results, or contract with third-party laboratories for that testing. The manufacturer shall pay for the costs of testing the manufacturer’s products before the testing is conducted.
(2)Any charges collected by the department pursuant to this subdivision shall be deposited into the T.A.M.P.O.N. Act Fund, as

described in Section 25258.6, and shall be made available, upon appropriation by the Legislature, to the department for purposes of implementing this section, including, but not limited to, the

administration of chemical testing pursuant to, and the oversight of manufacturers’ compliance with, this section.

(f)The department may publish any analytical test results received from manufacturers or obtained through its own testing, along with any departmental analysis of these results. The department may also provide information regarding the potential health impacts associated with the presence of specific chemicals in disposable tampon or pad products by making the information available to the public in a searchable format on the department’s internet website.